CERO THERAPEUTICS HOLDINGS, INC. - 8-K Filing
Cero Therapeutics entered into a $2.085M convertible loan with SRX Global Inc., funded in three tranches totaling $2.085M as of July 14, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $PBAXU